Eicosapentaenoic acid monoglycerid (MAG-EPA)
IO3-04
Approved other completed
Quick answer
Eicosapentaenoic acid monoglycerid (MAG-EPA) for Inflammation is a Approved program (other) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTEGRATED BIOPHARMA INC
- Indication
- Inflammation
- Phase
- Approved
- Modality
- other
- Status
- completed